3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
4
Gastrointestinal
3
CNS
3
Sarcoma
2
Thoracic
1
Head & Neck
1
Endocrine
1
Breast
1
Conditions
Sarcoma
2
Neoplasms
1
Carcinoma, Adenoid Cystic
1
Interventions
Doxorubicin
25
Cyclophosphamide
24
pembrolizumab
20
Specimen Handling
19
Temozolomide
16
Surgical Procedures, Operative
14
Magnetic Resonance Spectroscopy
14
Gemcitabine
13
Blood Specimen Collection
13
Biopsy
13
Radiotherapy
12
fludarabine
11
atezolizumab
11
Vincristine
11
Ifosfamide
11
X-Rays
8
Trabectedin
8
Nivolumab
8
Irinotecan
8
Imatinib Mesylate
8
Drug Therapy
8
cabozantinib
7
Surveys and Questionnaires
7
Radiation
6
selinexor
5
liposomal doxorubicin
5
Sunitinib
5
Standard of Care
5
Radiation Dose Hypofractionation
5
Dactinomycin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Protons
×
Sarcoma
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled
NCT02838602
2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA
Recruiting
250 enrolled